Dr. Ted Love
Cardiovascular Disease · San Francisco, CA
CMS Profile ID: 290561 · NPI: 1417299728
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$689,946
Number of Payments
46
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Consulting Fee | $479,007 |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $209,253 |
| Food and Beverage | $1,233 |
| Travel and Lodging | $454 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| Gilead Sciences, Inc. | $461,877 |
| Tarsus Pharmaceuticals, Inc. | $228,003 |
| Ultragenyx Pharmaceutical Inc. | $65 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?